首頁 › 急性髓系白血病 › 康乃狄克 › Bridgeport
Bridgeport, CT 的 急性髓系白血病 臨床試驗
12 項針對 急性髓系白血病 的研究正在 Bridgeport（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
招募中2 期
- Stony Brook University Medical Center, Stony Brook · 距離 18 英里
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中觀察性研究歡迎健康志工
- Stony Brook University Medical Center, Stony Brook · 距離 18 英里
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
招募中2 期
- Stony Brook University Medical Center, Stony Brook · 距離 18 英里
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
招募中2 期
- Stony Brook University Medical Center, Stony Brook · 距離 18 英里
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
招募中2 期
- Stony Brook University Medical Center, Stony Brook · 距離 18 英里
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
招募中2 期
- Stony Brook University Medical Center, Stony Brook · 距離 18 英里
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
招募中3 期
- Stony Brook University Medical Center, Stony Brook · 距離 18 英里
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
招募中1/2 期
- Stony Brook University Medical Center, Stony Brook · 距離 18 英里
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
招募中1 期
- Stony Brook Cancer Center, Stony Brook · 距離 18 英里
Acute Myeloid Leukemia and Markers of Leukemia Stem Cells (CLL1 and CD45RA)
招募中觀察性研究
- Stony Brook Cancer Center, Stony Brook · 距離 18 英里
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
招募中觀察性研究
- Stony Brook University Hospital, Stony Brook · 距離 18 英里
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
招募中1 期
- Stony Brook University Hospital, Stony Brook · 距離 18 英里
其他城市的 急性髓系白血病 試驗
- Houston, TX85 項研究
- New York City, NY51 項研究
- Boston, MA44 項研究
- Seattle, WA41 項研究
- Baldwin Park, CA40 項研究
- Columbus, OH35 項研究
- Philadelphia, PA34 項研究
- Durham, NC33 項研究
- Atlanta, GA31 項研究
- Tampa, FL29 項研究
- Chicago, IL26 項研究
- Portland, OR25 項研究
Bridgeport 的其他研究
- 乳癌21 項研究
- 非小細胞肺癌14 項研究
- 肺癌13 項研究
- 心血管疾病9 項研究
- 癌症（所有類型）8 項研究
- 頭頸部鱗狀細胞癌8 項研究
- 轉移性癌症7 項研究
- 心臟衰竭7 項研究
- 腦動脈瘤6 項研究
- 多發性骨髓瘤6 項研究
- 前列腺癌6 項研究
- 卵巢癌5 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。